Sofia R Gameiro Selected Research

Sofia R Gameiro Research Topics

Disease

35	Neoplasms (Cancer) 01/2022 - 09/2011
14	Carcinoma (Carcinomatosis) 01/2022 - 09/2011
7	Prostatic Neoplasms (Prostate Cancer) 11/2018 - 06/2010
6	Breast Neoplasms (Breast Cancer) 01/2020 - 02/2016
3	Neoplasm Metastasis (Metastasis) 01/2019 - 02/2012
2	Inflammation (Inflammations) 01/2022 - 01/2020
2	Necrosis 01/2021 - 01/2013
2	Chordoma 11/2018 - 05/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2018 - 02/2012
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018
1	Triple Negative Breast Neoplasms 04/2016
1	Hyperthermia 01/2013

Drug/Important Bio-Agent (IBA)

11	VaccinesIBA 01/2022 - 06/2010
10	AntigensIBA 01/2020 - 02/2012
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2014
6	Immune Checkpoint InhibitorsIBA 01/2022 - 06/2013
6	Histone Deacetylase InhibitorsIBA 01/2022 - 02/2016
6	entinostat (MS 275)IBA 01/2022 - 02/2016
5	Cancer VaccinesIBA 01/2022 - 06/2010
5	Interleukin-12 (IL 12)IBA 01/2022 - 01/2019
5	Interleukin-15 (Interleukin 15)IBA 01/2022 - 01/2019
5	CytokinesIBA 01/2021 - 02/2012
4	Granzymes (Granzyme)IBA 01/2020 - 02/2012
4	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 01/2013
4	CalreticulinIBA 12/2016 - 01/2014
3	LigandsIBA 01/2022 - 01/2018
3	Immunoglobulin G (IgG)IBA 01/2020 - 01/2018
3	Brachyury protein (Brachyury)IBA 01/2020 - 02/2016
3	Monoclonal AntibodiesIBA 01/2019 - 01/2018
3	Carcinoembryonic AntigenIBA 05/2016 - 02/2012
3	AndrogensIBA 04/2016 - 10/2014
2	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 05/2014
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	B7-H1 AntigenIBA 01/2022 - 01/2020
2	ALT-803IBA 01/2020 - 01/2019
2	Death Domain ReceptorsIBA 11/2018 - 01/2018
2	avelumabIBA 11/2018 - 01/2018
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2018 - 02/2016
2	Vorinostat FDA Link 01/2018 - 02/2016
2	Protons (Proton)IBA 12/2016 - 05/2016
2	abirateroneIBA 04/2016 - 10/2014
2	Androgen Receptors (Androgen Receptor)IBA 04/2016 - 10/2014
2	enzalutamideIBA 04/2016 - 10/2014
2	Adenosine Triphosphate (ATP)IBA 01/2014 - 08/2013
2	HMGB1 Protein (HMG1)IBA 01/2014 - 08/2013
2	PlatinumIBA 02/2012 - 09/2011
2	Cisplatin (Platino)FDA LinkGeneric 02/2012 - 09/2011
2	Vinorelbine (Navelbine)FDA LinkGeneric 02/2012 - 09/2011
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Interleukin-12 Receptors (Interleukin 12 Receptor)IBA 01/2022
1	CollagenIBA 01/2022
1	ProteomeIBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2020
1	Ado-Trastuzumab EmtansineIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Blocking AntibodiesIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Cetuximab (Erbitux)FDA Link 11/2018
1	olaparibIBA 11/2018
1	adavosertibIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Complement System Proteins (Complement)IBA 01/2018
1	RadiopharmaceuticalsIBA 12/2016
1	Radium-223IBA 12/2016
1	Mucin-1 (CA 15-3 Antigen)IBA 05/2016
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 05/2016
1	OsteoprotegerinIBA 04/2016
1	Estrogen ReceptorsIBA 04/2016
1	Histone Deacetylase 1IBA 02/2016
1	Hormones (Hormone)IBA 10/2014
1	Biological ProductsIBA 01/2014
1	Docetaxel (Taxotere)FDA Link 08/2013
1	Histocompatibility Antigens Class IIBA 01/2013
1	ChemokinesIBA 02/2012
1	PerforinIBA 02/2012
1	yeast-CEA vaccineIBA 09/2011

Therapy/Procedure

16	Immunotherapy 01/2020 - 02/2012
14	Therapeutics 01/2022 - 06/2010
9	Drug Therapy (Chemotherapy) 01/2020 - 06/2010
4	Radiotherapy 01/2015 - 01/2014
3	Castration 12/2016 - 06/2010
1	Aftercare (After-Treatment) 08/2013
1	Radiofrequency Ablation 01/2013
1	Brachytherapy 02/2012